Hepatic Encephalopathy: From the Pathogenesis to the New Treatments. (Q30381016)

12 October 2017

1 reference

title

Hepatic Encephalopathy: From the Pathogenesis to the New Treatments. (English)

1 reference

12 October 2017

1 reference

hepatic encephalopathy

1 reference

Juan Cordoba

1

1 reference

12 October 2017

4 June 2014

1 reference

12 October 2017

1 reference

12 October 2017

2014

1 reference

12 October 2017

236268

1 reference

Creative Commons Attribution 3.0 Unported

12 October 2017

start time

4 June 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Safety of ornithine phenylacetate in cirrhotic decompensated patients: an open-label, dose-escalating, single-cohort study.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Meta-analysis: The diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Systemic inflammation and ammonia in hepatic encephalopathy.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Brain magnetic resonance spectroscopy in episodic hepatic encephalopathy.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Rifaximin vs. conventional oral therapy for hepatic encephalopathy: a meta-analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

New assessment of hepatic encephalopathy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Altered glial-neuronal crosstalk: cornerstone in the pathogenesis of hepatic encephalopathy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Rifaximin treatment in hepatic encephalopathy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Review article: the modern management of hepatic encephalopathy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Pathogenetic mechanisms of hepatic encephalopathy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Glutamine: a Trojan horse in ammonia neurotoxicity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Predictive value of arterial ammonia for complications and outcome in acute liver failure

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Pathophysiology of hepatic encephalopathy: a new look at GABA from the molecular standpoint

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Neuropsychological characterization of hepatic encephalopathy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Hepatic encephalopathy: a neuropsychiatric disorder involving multiple neurotransmitter systems

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Pathophysiology of cerebral edema in fulminant hepatic failure.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Subclinical hepatic encephalopathy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Noninvasive neuroinvestigation in liver disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Cerebral circulation in liver failure: Ohm's law in force.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Brain edema and hepatic encephalopathy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Natural benzodiazepines and hepatic encephalopathy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Astrocytic-ammonia interactions in hepatic encephalopathy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Difficult management problems in fulminant hepatic failure.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Hepatic myelopathy: a rare complication of portacaval shunt

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

False neurotransmitters and hepatic failure.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study)

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Biochemistry and physiology of brain ammonia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Neuropsychological deficits and morphological MRI brain scan abnormalities in apparently healthy non-encephalopathic patients with cirrhosis. A controlled study.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Branched chain amino acids in the management of chronic liver disease. Facts and fantasies

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Regional cerebral blood flow and cognitive function in patients with chronic liver disease.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

The effect of oral-administered lactulose on colonic nitrogen metabolism and excretion

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake.

20 June 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Effect of intrahepatic portal-systemic shunting on hepatic ammonia extraction in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Increased brain concentrations of a neuroinhibitory steroid in human hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Gut bacteria provide precursors of benzodiazepine receptor ligands in a rat model of hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Hemoglobin metabolites mimic benzodiazepines and are possible mediators of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Cerebral oedema and increased intracranial pressure in chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Mini-asterixis in hepatic encephalopathy induced by pathologic thalamo-motor-cortical coupling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Bright basal ganglia in T1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

The hyperventilation of cirrhosis: progesterone and estradiol effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Chronic portosystemic hepatic encephalopathy refractory to medical treatment successfully reversed by liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Neuropsychological characterization and detection of subclinical hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Neuropsychological abnormalities in cirrhosis include learning impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Critical flicker frequency for quantification of low-grade hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Detection of human Bocavirus 1, 2 and 3 from patients with acute gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Minimal hepatic encephalopathy impairs fitness to drive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Partial pressure of ammonia versus ammonia in hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

ESPEN guidelines for nutrition in liver disease and transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Normal protein diet for episodic hepatic encephalopathy: results of a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Rifaximin, a non-absorbable rifamycin, for the treatment of hepatic encephalopathy. A double-blind, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Falls and cognitive dysfunction impair health-related quality of life in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Neurophysiological assessment of early hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F236268

Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Update on the management of hepatic encephalopathy

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Cyclic treatment of chronic hepatic encephalopathy with rifaximin. Results of a double-blind clinical study.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

The neurological disorder associated with liver disease.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4890879

Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma

26 November 2018

1 reference

12 December 2020

Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis: a cohort study

1 reference

12 December 2020

Development of a clinical hepatic encephalopathy staging scale

1 reference

12 December 2020

Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study

1 reference

12 December 2020

Acute hepatic encephalopathy in the rat: the effect of cross-circulation

1 reference

12 December 2020

Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis

1 reference

12 December 2020

Infection, inflammation and hepatic encephalopathy, synergism redefined

1 reference

12 December 2020

Elevated intracranial pressure and computed tomography of the brain in fulminant hepatocellular failure

1 reference

12 December 2020

Effects of Branched-Chain Amino Acids Supplementation in Patients With Cirrhosis and a Previous Episode of Hepatic Encephalopathy: A Randomized Study

1 reference

12 December 2020

Exercise-induced hyperammonemia in patients with compensated chronic liver disease

1 reference

12 December 2020

Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy

1 reference

12 December 2020

Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease

1 reference

12 December 2020

Prevalence of brain atrophy in liver cirrhosis patients with chronic persistent encephalopathy. Evaluation by computed tomography

1 reference

12 December 2020

Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration

1 reference

12 December 2020

The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis

1 reference

12 December 2020

Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy

1 reference

12 December 2020

Bradykinesia in minimal hepatic encephalopathy is due to disturbances in movement initiation

1 reference

12 December 2020

Hepatic Encephalopathy

1 reference

12 December 2020

Rifaximine versus neomycin in the treatment of portosystemic encephalopathy

1 reference

12 December 2020

The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis

1 reference

12 December 2020

Increased signals seen in globus pallidus in T1-weighted magnetic resonance imaging in cirrhotics are not suggestive of chronic hepatic encephalopathy

1 reference

12 December 2020

Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure

1 reference

12 December 2020

Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy

1 reference

12 December 2020

Identifiers

DOI

10.1155/2014/236268

1 reference

12 October 2017

1 reference

12 October 2017

1 reference

PMCID

4890879